Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,648.00
Bid: 2,652.00
Ask: 2,654.00
Change: 8.00 (0.30%)
Spread: 2.00 (0.075%)
Open: 2,642.00
High: 2,666.00
Low: 2,636.00
Prev. Close: 2,640.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Inclusion in the FTSE UK Index Series

12 Sep 2013 07:00

RNS Number : 7769N
Coca-Cola HBC AG
12 September 2013
 



Coca-Cola HBC AG

Inclusion in the FTSE UK Index Series

 

Zug, Switzerland- 12 September 2013 - Coca-Cola HBC AG ("Coca‑Cola HBC") today announces its inclusion into the FTSE 100 and FTSE All - Share indices.

 

Coca‑Cola HBC notes the announcement issued on 11 September 2013 by FTSE, confirming that Coca‑Cola HBC will be included as a constituent of the FTSE 100 and FTSE All - Share indices from close of business on 20 September.

 

On 29 April 2013, Coca‑Cola HBC was admitted to the premium listing segment of the Official List of the UK Listing Authority and to trading on the main market for listed securities of the London Stock Exchange. In addition, the ordinary shares of Coca‑Cola HBC are admitted to the main market of the Athens Exchange with a secondary listing, while its American depository shares are trading on the New York Stock Exchange.

 

Commenting on today's announcement, Dimitris Lois, CEO of Coca-Cola HBC, said:

"This is another milestone for our company and an important day for everyone in the Coca‑Cola HBC family. We are delighted that we are now included in the FTSE 100 and FTSE All - Share indices. We expect this to further benefit our shareholders through enhanced liquidity and our company by facilitating its access to a wider pool of institutional investors."

 

 

Enquiries

Coca‑Cola HBC Group

Oya Gur

Investor Relations Director

Tel: +30 210 618 3255

email: oya.gur@cchellenic.com

 

Eri Tziveli

Investor Relations Manager

Tel: +30 210 618 3133

email: eri.tziveli@cchellenic.com

 

Dimitris Bakas

Investor Relations Manager

Tel: +30 210 618 3124

email: dimitris.bakas@cchellenic.com

 

International media contact:

 

RLM Finsbury

Guy Lamming

Charles Chichester

Philip Walters

Charles O' Brien

 

Tel: +44 20 7251 3801

email: guy.lamming@rlmfinsbury.com

email: charles.chichester@rlmfinsbury.com

email: philip.walters@rlmfinsbury.com

email: charles.o'brien@rlmfinsbury.com

 

Greek media contact:

 

V+O Communications

Mary Andreadi

Tel: +30 211 7501223

email: ma@vando.gr

 

 

 

About Coca‑Cola HBC Group

Coca-Cola HBC is the second-largest bottler of products of The Coca-Cola Company in terms of volume with sales of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 581 million people. Coca-Cola HBC offers a diverse range of ready-to-drink non-alcoholic beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca‑Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities.

 

Coca-Cola HBChas a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). Coca-Cola HBC's American depositary shares (ADSs) are listed on the New York Stock Exchange (NYSE: CCH). Coca-Cola HBC is included in the Dow Jones Sustainability and FTSE4Good Indexes. For more information, please visit http://www.coca-colahellenic.com/.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFIFIFFDSEFU
Date   Source Headline
31st May 20245:25 pmRNSTransaction in Own Shares
30th May 20245:36 pmRNSTransaction in Own Shares
29th May 20243:25 pmRNSDirector/PDMR Shareholding
29th May 20243:19 pmRNSDirector/PDMR Shareholding
28th May 202410:07 amRNSDirector/PDMR Shareholding
28th May 202410:04 amRNSDirector/PDMR Shareholding
22nd May 20245:43 pmRNSDirector/PDMR Shareholding
21st May 20246:01 pmRNSComposition of the Board Committees
21st May 20245:55 pmRNSResult of AGM
20th May 20244:44 pmRNSDirector/PDMR Shareholding
15th May 20244:19 pmRNSDirector/PDMR Shareholding
13th May 202411:30 amRNSDirector/PDMR Shareholding
8th May 20245:50 pmRNSTransaction in Own Shares
7th May 20245:29 pmRNSTransaction in Own Shares
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement
22nd Mar 20245:05 pmRNSTransaction in Own Shares
21st Mar 20245:40 pmRNSTransaction in Own Shares
20th Mar 20245:33 pmRNSTransaction in Own Shares
19th Mar 20245:20 pmRNSTransaction in Own Shares
19th Mar 20241:19 pmRNSDirector/PDMR Shareholding
18th Mar 20245:20 pmRNSTransaction in Own Shares
15th Mar 20246:25 pmRNSTransaction in Own Shares
15th Mar 20245:58 pmRNSAnnual Financial Report
14th Mar 20245:30 pmRNSTransaction in Own Shares
14th Mar 20243:04 pmRNSDirector/PDMR Shareholding
14th Mar 20242:56 pmRNSDirector/PDMR Shareholding
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:15 pmRNSTransaction in Own Shares
11th Mar 20245:50 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.